Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aplife Biotech
Buenos Aires, Argentinaaplifebiotech.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
Aplife Biotech is developing a high-throughput platform called AptiveX for the rapid discovery and optimization of aptamers and other molecular probes. The technology enables the synthesis and screening of millions of compounds on CMOS chips to accelerate biosensor development, diagnostic assay creation, and potentially therapeutic lead identification. The company is at the prototype-ready stage with no clinical results reported yet[3][4][8].
- Therapeutic areas
- Other
- Modalities
- AptamerSynthetic oligonucleotideSmall molecule (potential, as part of combinatorial libraries)
- Industry
- Drug Discovery Services
02
Partnerships
Grid Exponential (GRIDX)Conicet
Beyond the preview
Go deeper on Aplife Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aplife Biotech.